Skip to content

Clinical trials

Phase 1 HIV Infections trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: HIV Infections Phase: Phase 1 Country / region: United States Clear all

668 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20008
20012
20025
20038
200417
200519
200627
200726
200815
200922
201015
201111
20124
20134
201410
201514
20168
201718
201811
201916
202013
202110
20228
20235
20249
20258
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed598
Terminated25
Unknown status17
Active, not recruiting13
Recruiting8
Withdrawn6
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)340
ViiV Healthcare51
National Cancer Institute (NCI)17
Bristol-Myers Squibb15
Gilead Sciences9
Glaxo Wellcome8
International AIDS Vaccine Initiative8
Rhode Island Hospital7
University of Pennsylvania7
Boehringer Ingelheim6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
HIV Infections668
Acquired Immunodeficiency Syndrome210
AIDS-Related Complex98
Sarcoma, Kaposi23
AIDS-Related Opportunistic Infections18
Pregnancy Complications, Infectious15
Vaccinia14
Infections12
Cytomegalovirus Infections10
Multiple Acyl Coenzyme A Dehydrogenase Deficiency9

Trials

Showing 1 to 25 of 668. Each trial links to its page on Pharma Observatory.

568 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.